Your browser doesn't support javascript.
loading
Multicenter study of QuantiFERON®-TB Gold Plus in patients with active tuberculosis.
Horne, D J; Jones, B E; Kamada, A; Fukushima, K; Winthrop, K L; Siegel, S A R; Kovacs, A; Anthony, P; Meekin, K A; Bhat, S; Kerndt, P; Chang, A; Koelle, D M; Narita, M.
Afiliación
  • Horne DJ; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Department of Global Health, Firland Northwest TB Center, University of Washington, Seattle, Washington.
  • Jones BE; Division of Infectious Diseases, Department of Medicine, University of Southern California, Los Angeles, California, USA.
  • Kamada A; National Hospital Organization Hokkaido Medical Center, Sapporo.
  • Fukushima K; Division of Respiratory Medicine, Japanese Red Cross Nagasaki Genbaku Isahaya Hospital, Nagasaki, Japan.
  • Winthrop KL; Division of Infectious Diseases, Department of Medicine, Oregon Health & Science University, Portland, School of Public Health, Oregon Health & Science University, Portland State University, Portland, Oregon.
  • Siegel SAR; School of Public Health, Oregon Health & Science University, Portland State University, Portland, Oregon.
  • Kovacs A; Maternal, Child, and Adolescent Virology Research Laboratory, University of Southern California, Los Angeles.
  • Anthony P; Maternal, Child, and Adolescent Virology Research Laboratory, University of Southern California, Los Angeles.
  • Meekin KA; Maternal, Child, and Adolescent Virology Research Laboratory, University of Southern California, Los Angeles.
  • Bhat S; Division of Infectious Diseases, Department of Medicine, University of Southern California, Los Angeles, California, USA.
  • Kerndt P; TB Control Program, Los Angeles County Department of Public Health, Los Angeles, California.
  • Chang A; TB Control Program, Los Angeles County Department of Public Health, Los Angeles, California.
  • Koelle DM; Department of Global Health, Division of Allergy and Infectious Diseases, Department of Medicine, Department of Laboratory Medicine, University of Washington, Seattle, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Benaroya Research Institute, Seattle.
  • Narita M; Division of Pulmonary, Critical Care, and Sleep Medicine, Department of Medicine, Department of Global Health, Firland Northwest TB Center, University of Washington, Seattle, Washington, Benaroya Research Institute, Seattle.
Int J Tuberc Lung Dis ; 22(6): 617-621, 2018 06 01.
Article en En | MEDLINE | ID: mdl-29862944
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis / Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / Ensayos de Liberación de Interferón gamma Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 3_ND Problema de salud: 3_neglected_diseases / 3_tuberculosis Asunto principal: Tuberculosis / Linfocitos T CD4-Positivos / Linfocitos T CD8-positivos / Ensayos de Liberación de Interferón gamma Tipo de estudio: Clinical_trials / Diagnostic_studies Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: America do norte / Asia Idioma: En Revista: Int J Tuberc Lung Dis Año: 2018 Tipo del documento: Article